vimarsana.com
Home
Live Updates
Pulse Biosciences Announces First-in-Human Procedures with i
Pulse Biosciences Announces First-in-Human Procedures with i
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX Nanosecond Pulsed Field Ablation (nsPFA) Cardiac Catheter
Company’s proprietary system used to treat initial five patients in first-in-human feasibility study for patients with atrial fibrillation
Related Keywords
Prague ,
Praha ,
Hlavníesto ,
Czech Republic ,
Kevin Danahy ,
Vivek Reddy ,
Petr Neuzil ,
Bioscience Cell ,
Company Cell ,
Arrhythmia Services At Mount Sinai Hospital ,
Pulse Biosciences Inc ,
Pulse Biosciences ,
Pulsed Field Ablation ,
Cardiac Arrhythmia Services ,
Mount Sinai Hospital ,
Map System ,
Gan Dunnington ,
Chief Medical Officer ,
Cardiac Surgery ,